CE Usage Diagnostic In Vitro REF PTO2 R1 5x2 mL R2 1 x12 mL PTO5 R1 10 x 5 mL R2 1 x 60 mL Fabriqu en France Version 18 12 2014 PRINCIPE DE LA METHODE M thode de Quick et al La thromboplastine tissulaire et le calcium sont ajout s au plasma citrat activant ainsi les facteurs du syst me de coagulation extrins que contenus dans le plasma Le temps de coagulation temps de formation du caillot de fibrine est mesur 37 C SIGNIFICATIO
Pacific Hemostasis Thromboplastin D VI VII VIII Intended Use Pacific Hemostasis Thromboplastin D is intended for use in performing the one stage prothrombin time PT test and PT based factor assays Summary and Principles The PT is used as a screening tool and as a quantitative test for coagulation factors in the extrinsic and common pathways This test will be prolonged in patients with acquired or congenital disorders that reduce the activity of factor